Study protocol: HiSNAP trial – a multi-centre, randomised, open label, blinded end-point, safety and efficacy trial of conventional (300mg/kg) versus higher doses of acetylcysteine (450mg/kg and 600mg/kg) in patients with paracetamol overdose in the United Kingdom
View ORCID ProfileChristopher Humphries, View ORCID ProfileEllise Clarke, Michael Eddleston, Marianne Gillings, Sîan Irvine, Liza Keating, Anna Miell, Lynsey Milne, Laura Muir, Rachel O’Brien, Katherine Oatey, Rajendra Raman, Ruben Thanacoody, Sharon Tuck, View ORCID ProfileChristopher J Weir, David M Wood, View ORCID ProfileJames W Dear HiSNAP Trial Investigators
doi: https://doi.org/10.1101/2024.11.12.24317178
Christopher Humphries
1Centre for Cardiovascular Science, University of Edinburgh, The Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK
Ellise Clarke
2Emergency Medicine Research Group Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK
Michael Eddleston
1Centre for Cardiovascular Science, University of Edinburgh, The Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK
Marianne Gillings
3HiSNAP Trial Steering Committee, Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Sîan Irvine
4Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Liza Keating
5HiSNAP Data Monitoring Committee, Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Anna Miell
2Emergency Medicine Research Group Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK
Lynsey Milne
4Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Laura Muir
3HiSNAP Trial Steering Committee, Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Rachel O’Brien
2Emergency Medicine Research Group Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK
Katherine Oatey
4Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Rajendra Raman
6Victoria Hospital, Hayfield Road, Kirkcaldy, KY2 5AH
Ruben Thanacoody
3HiSNAP Trial Steering Committee, Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Sharon Tuck
4Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
Christopher J Weir
4Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
David M Wood
5HiSNAP Data Monitoring Committee, Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, EH16 4UX, UK
James W Dear
1Centre for Cardiovascular Science, University of Edinburgh, The Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK
Posted November 12, 2024.
Study protocol: HiSNAP trial – a multi-centre, randomised, open label, blinded end-point, safety and efficacy trial of conventional (300mg/kg) versus higher doses of acetylcysteine (450mg/kg and 600mg/kg) in patients with paracetamol overdose in the United Kingdom
Christopher Humphries, Ellise Clarke, Michael Eddleston, Marianne Gillings, Sîan Irvine, Liza Keating, Anna Miell, Lynsey Milne, Laura Muir, Rachel O’Brien, Katherine Oatey, Rajendra Raman, Ruben Thanacoody, Sharon Tuck, Christopher J Weir, David M Wood, James W Dear
medRxiv 2024.11.12.24317178; doi: https://doi.org/10.1101/2024.11.12.24317178
Study protocol: HiSNAP trial – a multi-centre, randomised, open label, blinded end-point, safety and efficacy trial of conventional (300mg/kg) versus higher doses of acetylcysteine (450mg/kg and 600mg/kg) in patients with paracetamol overdose in the United Kingdom
Christopher Humphries, Ellise Clarke, Michael Eddleston, Marianne Gillings, Sîan Irvine, Liza Keating, Anna Miell, Lynsey Milne, Laura Muir, Rachel O’Brien, Katherine Oatey, Rajendra Raman, Ruben Thanacoody, Sharon Tuck, Christopher J Weir, David M Wood, James W Dear
medRxiv 2024.11.12.24317178; doi: https://doi.org/10.1101/2024.11.12.24317178
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2940)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4582)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4350)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6935)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)